Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observational study of intranasal glucagon (AMG504-1) for hypoglycemia in children and adolescents with type 1 diabetes
2015-003732-12Phase 3
- Sponsor
- Locemia Solutions
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of glucagon in hypoglycaemia, sponsored by Locemia Solutions. Primary endpoint: Overall response rate.
02
Drugs
glucagon
03
Conditions
hypoglycaemia
Beyond the preview
Go deeper on 2015-003732-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003732-12.